Cancer Biology
Cancer systems biology encompasses the application of systems biology approaches to cancer research, in order to study the disease as a complex adaptive system with emerging properties at multiple biological scales.More explicitly, because cancer spans multiple biological, spatial and temporal scales, communication and feedback mechanisms across the scales create a highly complex dynamic system. The relationships between scales is not simple or necessarily direct, and sometimes become combinatorial, so that systems approaches are essential to evaluate these relationships quantitatively and qualitatively.
Products for Cancer Biology
- Cat.No. Product Name Information
-
BCC1015
Laminin (925-933)
Laminin (925-933) is a peptide derived from residues 925-933 of the Laminin B1 chain that binds to the laminin receptor.
-
BCC3973
AI-10-49
AI-10-49 is a protein-protein interaction inhibitor that selectively binds to CBFβ-SMMHC and disrupts its binding to RUNX1 with a FRET IC50 of 0.26 uM.
-
BCC1018
Cadherin Peptide, avian
-
BCC1022
[Ser25] Protein Kinase C (19-31)
-
BCC5605
CE3F4
CE3F4 is a selective antagonist of exchange protein directly activated by cAMP (Epac1), with IC50s of 10.7 μM and 66 μM for Epac1 and Epac2(B), respectively.
-
BCC1019
Fas C- Terminal Tripeptide
-
BCC1048
β-Pompilidotoxin
Slows neuronal Na+ channel inactivation
-
BCC1034
Dynamin inhibitory peptide
Dynamin inhibitor
-
BCC5569
RBC8
RBC8 is a novel small molecule inhibitor of Ral GTPase; has IC50 of 3.5 μM in H2122 cell and 3.4 μM in H358 cell.
-
BCC1038
Cytochrome c - pigeon (88-104)
-
BCC1021
Adrenorphin
Adrenorphin is a opioid octapeptide, acting as a potent agonist of μ-opioid receptor, with Ki of 12 nM.
-
BCC1014
Epidermal Growth Factor Receptor Peptide (985-996)